Advances in Canine Hemangiosarcoma: From Evidence to Emerging Targets
Overview
This session provides a concise, evidence-based update on canine haemangiosarcoma, with a strong focus on contemporary treatment strategies. It includes a brief, targeted review of current literature outlining standard-of-care approaches, outcomes, and the limitations of existing therapies.
Building on this foundation, recent advances in molecular sequencing and genomic profiling are explored, highlighting how these technologies are deepening our understanding of tumour biology and uncovering novel, actionable treatment targets. Practical clinical implications and future directions for personalised therapy in veterinary oncology are also discussed, making the content highly relevant for veterinarians involved in the diagnosis and management of this challenging disease.
Presenters
DipECVIM-CA (Oncology) MANZCVS (Oncology) PGCert VetEd FHEA MRCVS CVLM
Pet Cancer Care
